Article Details
Retrieved on: 2024-08-12 13:59:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
So far, anti-PD-1 monoclonal antibodies have only been approved for the second-line or beyond treatment of advanced melanoma in China, however ...
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here